相关实验视频
加瓦尔酸联合治疗与单一治疗用于预防双相I型精神障碍的复发 (BALANCE):一个随机的开放标签试验
1, John R Geddes, Guy M Goodwin
1Oxford Clinical Trials Unit for Mental Illness, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK. john.geddes@psych.ox.ac.uk
Lancet (London, England)
|January 23, 2010
概括
与和氨酸的联合治疗,以及单独使用,在预防双相I型情绪障碍复发方面比单独使用氨酸更有效. 这一发现为患有情绪发作的患者提供了更好的治疗选择.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 二极性I型障碍的复发是导致残疾的一个重要原因.
- 碳酸和半酸是推的单一疗法,但往往缺乏充分的疗效.
- 组合疗法可以提供更好的复发预防.
研究的目的:
- 为了比较加瓦尔酸联合治疗与单独治疗的疗效,用于预防双相I型躁郁症的复发.
- 评估组合疗法是否提供优越的复发预防与或氨酸单一疗法相比.
主要方法:
- 一个随机的,开放的标签试验,涉及330名患有双相I型精神障碍的患者.
- 参与者接受了单疗法,酸单疗法或两者的组合.
- 随访时间长达24个月,主要结果是针对突发情绪发作启动新的干预措施.
主要成果:
- 组合疗法 (54%) 和单疗法 (59%) 与酸单疗法 (69%) 相比,主要结局事件的发生率较低.
- 组合疗法明显优于单独治疗的氨酸 (HR0.59,p=0.0023).
- 单疗也明显优于酸单疗 (HR 0.71,p=0.0472).
结论:
- 加瓦酸联合治疗和单疗比瓦酸单疗更有效地预防双相I型精神障碍的复发.
- 这些治疗的好处持续长达两年,并且独立于基线疾病严重程度.
- 该研究无法最终证实或驳斥组合治疗对单一治疗的益处.
相关概念视频
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications